“Efficacy and Safety of Omalizumab in Japanese and Korean Patients With Chronic Idopathic Spontaneous Urticaria (CIU CSU: Results from the Phase 3 POLARIS Study”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s126, https://doi.org/10.25251/skin.1.supp.125.